Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18808 | 469 | 31.8 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
851 | 11028 | KINDLING//ABSENCE EPILEPSY//EPILEPSY RESEARCH |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EXPTL EPILEPSIEFOR | Address | 4 | 75% | 1% | 3 |
2 | EXPERIMENTAL EPILEPSY MODELS | Author keyword | 2 | 67% | 0% | 2 |
3 | MODEL NERVOUS SYSTEM | Author keyword | 2 | 67% | 0% | 2 |
4 | PSYCHOMOTOR DYSFUNCTION | Author keyword | 2 | 67% | 0% | 2 |
5 | SENSORY SPINAL GANGLION CELLS | Author keyword | 2 | 67% | 0% | 2 |
6 | FOCAL INTERICTAL EPILEPTIFORM ACTIVITY | Author keyword | 1 | 100% | 0% | 2 |
7 | NON SYNAPTIC RELEASE | Author keyword | 1 | 50% | 0% | 2 |
8 | EXPT EPILEPSIEFOR | Address | 1 | 13% | 1% | 6 |
9 | SLOW POTENTIAL SHIFTS | Author keyword | 1 | 33% | 0% | 2 |
10 | EXPT EPILEPSY | Address | 1 | 17% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PAROXYSMAL NEURONAL DEPOLARIZATIONS | 7 | 64% | 1% | 7 |
2 | PAROXYSMAL DEPOLARIZATION SHIFTS | 6 | 80% | 1% | 4 |
3 | CA3 NEURONS | 5 | 21% | 4% | 20 |
4 | CALCIUM CHANNEL INHIBITORS | 3 | 39% | 1% | 7 |
5 | ANTIEPILEPTIC EFFICACY | 3 | 100% | 1% | 3 |
6 | PAROXYSMAL DEPOLARIZATION | 3 | 100% | 1% | 3 |
7 | SEIZURE INITIATION | 3 | 100% | 1% | 3 |
8 | EPILEPTIC DISCHARGES | 2 | 44% | 1% | 4 |
9 | INCREASED ANTIEPILEPTIC EFFICACY | 2 | 67% | 0% | 2 |
10 | REFRACTORY CHILDHOOD EPILEPSY | 2 | 50% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Calcium modulation in epilepsy | 2004 | 31 | 45 | 58% |
Basis of the antiseizure action of phenytoin | 1996 | 46 | 56 | 29% |
Epileptogenicity and epileptic activity: Mechanisms in an invertebrate model nervous system | 2004 | 7 | 29 | 59% |
Calcium antagonists as an add-on therapy for drug-resistant epilepsy | 2013 | 0 | 19 | 74% |
Transient neurologic deficits associated with carbamazepine-induced hypertension | 2003 | 2 | 5 | 60% |
ANTIEPILEPTIC DRUGS - PHARMACOLOGICAL MECHANISMS AND CLINICAL EFFICACY WITH CONSIDERATION OF PROMISING DEVELOPMENTAL STAGE COMPOUNDS | 1990 | 548 | 517 | 9% |
PHENYTOIN - MECHANISMS OF ITS ANTICONVULSANT ACTION | 1986 | 136 | 52 | 42% |
DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL WITH FLUNARIZINE IN THERAPY-RESISTANT EPILEPTIC PATIENTS | 1988 | 15 | 13 | 54% |
DC POTENTIALS OF THE CEREBRAL-CORTEX - SEIZURE ACTIVITY AND CHANGES IN GAS-PRESSURES | 1987 | 45 | 19 | 11% |
MECHANISMS OF ANTICONVULSANT DRUGS | 1988 | 4 | 15 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPTL EPILEPSIEFOR | 4 | 75% | 0.6% | 3 |
2 | EXPT EPILEPSIEFOR | 1 | 13% | 1.3% | 6 |
3 | EXPT EPILEPSY | 1 | 17% | 0.9% | 4 |
4 | OTTOWA HOSP | 1 | 50% | 0.2% | 1 |
5 | PHYSIOL ROBERT KOCH STR 27A | 1 | 50% | 0.2% | 1 |
6 | EPILEPSIEZENTRUM BETHEL | 0 | 11% | 0.4% | 2 |
7 | EXPT EPILEPTOL | 0 | 11% | 0.4% | 2 |
8 | EXPT NEUROCHEM | 0 | 11% | 0.4% | 2 |
9 | DIPART INGN BIOFIS ELETTRON | 0 | 100% | 0.2% | 1 |
10 | EXPTL EPILEPSIEFOR HUFFERSTR 68 | 0 | 100% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
2 | 0.0000221661 | PAROXYSMAL DEPOLARIZATION SHIFT//TWO COMPARTMENT NEURON//LOW MAGNESIUM ACSF |
3 | 0.0000134241 | BURSTS OF POTENTIAL//CENTRAL NEURON//BAG CELL NEURONS |
4 | 0.0000126141 | SR 33557//SR33805//H 3PN200 110 |
5 | 0.0000120662 | REMACEMIDE//LOSIGAMONE//REMACEMIDE HYDROCHLORIDE |
6 | 0.0000114072 | DOTARIZINE//DRUG INDUCED PARKINSONISM//CINNARIZINE |
7 | 0.0000109065 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
8 | 0.0000105499 | MOTOR SEIZURES//MED 3 PATHOPHYSIOL//POSTSYNAPTIC ELEMENT |
9 | 0.0000091781 | NIMODIPINE//EMOPAMIL//TC 81 |
10 | 0.0000077629 | ZITTER RAT//ATTRACTIN//SPONTANEOUSLY EPILEPTIC RAT SER |